Penumbra, Inc.

07/24/2026

From coordinating conference details to supporting events across the country, Jariell Jones thrives in a role where no two days are the same. Learn what drew her back to Penumbra and why helping bring people together is one of the most rewarding parts of her job. Read more here: https://www.penumbrainc.com/employee-spotlight-jariell-jones/. If you’d like to join our team, visit https://bit.ly/3z6E0Kx to learn more about career opportunities.

07/23/2026

The Penumbra APAC team hosted over 140 physicians from across the Asia-Pacific region for the annual Penumbra Innovations in Neuro & Vascular Outcomes and Therapies (PIVOT) Summit in Chiang Mai, Thailand from July 11-12, 2026.

Over the weekend, faculty and attendees engaged in rigorous case-based discussions, evidence reviews, and candid debate across some of the most pressing topics in neuro and vascular intervention today.

We are deeply grateful to every physician who travelled from across the globe to be part of this conversation, and to those who joined us virtually despite every obstacle. Your commitment to advancing patient care is what makes events like PIVOT Summit worth building.

07/22/2026

The results of the THUNDER IDE study evaluating Penumbra's THUNDERBOLT system was presented at . Read more here: https://peninc.info/4px1qCq

Society of NeuroInterventional Surgery

07/20/2026

Featured in MD+DI Penumbra President Shruthi Narayan discusses THUNDERBOLT, recent U.S. FDA clearance and CE Mark, and the evolution of computer assisted vacuum thrombectomy technology for acute ischemic stroke. Read more: https://peninc.info/4f5gnZ5

Penumbra secured FDA clearance and CE Mark for THUNDERBOLT, the first computer-assisted vacuum thrombectomy device for stroke treatment.

07/17/2026

US HCPs: In this case study, Dr. Marissa Famularo details Ruby XL Coils enabled ovarian vein embolization, reducing procedure time and cost while achieving symptom resolution. Read more on how design can make a difference in patient outcomes: https://peninc.info/4vEupWy.

Rx only. Risk info: peninc.info/risk Clinical results may vary.

07/07/2026

Penumbra announces the initiation of the FORWARD study with enrollment of the first patient. The international, prospective, multicenter study will evaluate mechanical thrombectomy, including computer assisted vacuum thrombectomy and modulated aspiration, for acute ischemic stroke with distal occlusions. Read more here: https://peninc.info/4y8cppX

06/15/2026

THUNDERBOLT has received CE Mark, expanding Penumbra’s computer assisted vacuum thrombectomy technology for neuro intervention to Europe. Read more here: https://peninc.info/49ZMuGu.

06/11/2026

Penumbra's THUNDERBOLT receives FDA clearance - bringing computer assisted vacuum thrombectomy technology to neuro intervention. Read more here: https://bit.ly/4uqFXMl.

06/11/2026

Penumbra has been named one of Business Insider's America's High Growth Companies of 2026. Driven by innovation and advanced technologies, we continue to expand our impact in healthcare and patient outcomes. Read more here: https://peninc.info/43lPDwG

These big corporations are showing strong growth across a variety of financial metrics.

06/04/2026

Now published in JSCAI: a STRIKE subgroup analysis evaluating outcomes with in pulmonary embolism. Read the full publication here: https://peninc.info/4mj439h

To learn more about the latest data visit: https://bit.ly/4avebXQ

Pulmonary embolism (PE) is a life-threatening condition that affects men and women at similar rates — but research has shown that women often face a more